Method of treating lower urinary tract disorders

Details for Australian Patent Application No. 2004227945 (hide)

Owner Dynogen Pharmaceuticals, Inc.

Inventors Landau, Steven B.; Miller, Cheryl L.; Fraser, Matthew O.

Agent Davies Collison Cave

Pub. Number AU-A-2004227945

PCT Pub. Number WO2004/089288

Priority 60/461,022 04.04.03 US; 60/496,502 20.08.03 US; 60/536,341 13.01.04 US

Filing date 2 April 2004

Wipo publication date 21 October 2004

Acceptance publication date 26 October 2006

International Classifications

A61K 031/551 - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

Event Publications

3 February 2005 PCT application entered the National Phase

  PCT publication WO2004/089288 Priority application(s): WO2004/089288

26 October 2006 Application Accepted

  Published as AU-A-2004227945

22 February 2007 Standard Patent Sealed

29 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004227949-System and method for dynamically performing storage operations in a computer network

2004227943-Novel compounds and compositions as protein kinase inhibitors